This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nissan Chemical Industries Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Koichi Yasutake: Innovator in Calcium Channel Inhibitors
Introduction
Koichi Yasutake is a prominent inventor based in Shiraoka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target calcium channels. His innovative work has the potential to impact pain management therapies.
Latest Patents
Yasutake holds a patent for a novel triazinone compound, which is specifically designed as a T-type calcium channel inhibitor. This compound exhibits excellent inhibitory activity on T-type voltage-dependent calcium channels, making it particularly useful for the treatment of pain. The patent details a compound of Formula (I), which includes various substituents defined in the claims, such as R groups and heteroaryl structures.
Career Highlights
Koichi Yasutake is associated with Nissan Chemical Industries Limited, where he has been instrumental in advancing research in pharmaceutical compounds. His work has led to the development of innovative solutions that address critical health issues.
Collaborations
Yasutake has collaborated with notable colleagues, including Noriko Saito and Jun Egi. Their combined expertise has contributed to the successful development of new therapeutic compounds.
Conclusion
Koichi Yasutake's contributions to the field of medicinal chemistry, particularly through his patent on triazinone compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in pain management therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile